|Articles|August 15, 2002
Focus on 0.15% version: Allergan discontinues brimonidine 0.2% solution
Irvine, CA-Allergan plans to discontinue U.S. distribution of its 0.2% brimonidine tartrate ophthalmic solution (Alphagan) because of what it calls the overwhelming popularity of its 0.15% counterpart, Alphagan P.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
























